Medical/Pharmaceuticals
Striving Together, Upgrading the Biopharma Industry - International Biopharma Industry Week Shanghai 2022 Kicks Off
SHANGHAI, Nov. 15, 2022 /PRNewswire/ -- On November 14, the opening ceremony of the second "International Biopharma Industry Week Shanghai" (hereinafter referred to as the "IBIWS 2022") took place in the Shanghai Zhangjiang Science Hall. Themed on "Striving Together, Upgrading the Biopharma Indus...
Peng Lei: RCEP countries to be first stop on NeuroXess' international expansion roadmap
SHANGHAI, Nov. 15, 2022 /PRNewswire/ -- The 2nd Asia Summit on Global Health, co-organized by the Hong Kong SAR Government and the Hong Kong Trade Development Council, got under way inHong Kong on November 10. The event brought together specialists in research and medicine from around the world a...
C&R Research, the Largest Korean CRO, Expands Partnership with Medidata to Enhance Their Clinical Operations
* C&R Research is the only CRO that authorized to Rave CTMS in Korea * Sponsors targeting global markets will manage clinical operations with these solutions that effectively support multinational clinical trials. SEOUL, South Korea, Nov. 15, 2022 /PRNewswire/ -- Medidata, a Dassault Systèmes ...
Innovent Announces First Participant Dosed in a Phase 3 Clinical Study (GLORY-1) of Mazdutide (IBI362) in Chinese Adults with Overweight or Obesity
ROCKVILLE, Md. and SUZHOU, China, Nov. 15, 2022 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology and ...
Everest Medicines Announces New Drug Application Acceptance by China NMPA for Nefecon for the Treatment of Primary IgA Nephropathy
-- NDA acceptance takes Everest closer to making this first-in-disease treatment available for primary IgAN patients inChina -- China is home to the largest patient base for IgAN with estimated 5 million people with the disease and currently there is no approved treatment in the country -- Nefe...
LumiraDx Continues Commercial Expansion of its Rapid Microfluidic Immunoassay HbA1c Test
Now Available in Europe, parts of the Middle East, Asia, Latin America, and Africa * Early customers include GP offices and other community-based healthcare settings * Latest figures, released as part of World Diabetes Day, reveal that 1 in 10 adults are now living with diabetes and nearly ...
NuraLogix Researchers Announce the Capability to Assess Type 2 Diabetes and Blood Biomarker Health Issues Using Any Video-Enabled Device
Facial blood flow patterns can predict a person's risk of pre-diabetes in just 30 seconds LAS VEGAS, Nov. 14, 2022 /PRNewswire/ -- Researchers at NuraLogix, a global pioneer of contactless health monitoring through its patented Transdermal Optical Imaging (TOI™) technology, has announced that it...
EMOTIV Partners with X-trodes to Launch New Medical-Grade, At-Home Solution for Brain Monitoring Research
Wearable Electrode Patches Provide Unprecedented Accuracy for Researchers
Measuring Brain and Physiological Signals Outside the Lab, Expanding
Possibilities for Real-World Clinical Studies
SAN FRANCISCO and HERZLIYA, Israel, Nov. 14, 2022 /PRNewswire/ -- EMOTIV
RedHill Accelerates Opaganib's Nuclear Radiation Protection Program - Positive Data Published
Strong preclinical data, recently published in the International Journal of Molecular Sciences, from eight U.S government-funded in-vivo opaganib studies, supports opaganib's potential as a nuclear radiation injury therapeutic for homeland security material threat medical countermeasures (MCM) an...
MGI Announces European Launch of New MGISP-Smart 8 Automated Sample Preparation System and Empowerment Program at MEDICA to Further Access to Genomics
DUSSELDORF, Germany, Nov. 14, 2022 /PRNewswire/ -- MGI, a company committed to building core tools and technology to lead life science, today announced the introduction of the latest MGISP-Smart 8 automated sample preparation system to Europe and the first iteration of its Empowerment Program at t...
SENTINEL DIAGNOSTICS LAUNCHES SENTINAT® 200, THE FULLY AUTOMATED SAMPLE TO RESULT SYSTEM FOR THE DIAGNOSIS OF VIRAL INFECTIONS
MILAN, Nov. 14, 2022 /PRNewswire/ -- Sentinel CH. SpA today announced the launch ofSENTiNAT® 200, the fully automated sample to result system, and STAT-NAT® SN200 Real-Time PCR assays for the quantitative detection of 10 viruses.SENTiNAT® 200 and STAT-NAT® SN200 kits represent the ideal soluti...
TauRx Announces Additional Investment of USD119 million following announcement of Phase 3 LUCIDITY Topline Results
* Substantial investment of USD119 million achieved by TauRx through a warrants exercise triggered by the announcement of LUCIDITY results in October, supporting HMTM regulatory submissions in UK, US andCanada, and preparation for market availability * Shareholder commitment to TauRx represen...
Mednovation Entered Into Strategic Cooperation With LSI
SHANGHAI, Nov. 14, 2022 /PRNewswire/ -- Mednovation is very pleased to announce that it has entered into a cooperation agreement with Life Science Intelligence, Inc. ("LSI") to promote the parties to the Medtech industry worldwide, and to cooperate with each other to support development and inno...
GENESIS MEDTECH UNVEILS NEW REVOLUTIONARY MEDTECH CAMPUS
* New campus combines R&D, manufacturing, and training with the latest state-of-art facilities * Brings innovation to next-level integration with medical professionals * Expected to reach industrial-scale production levels with an output value of over10 billion RMB (approximately US$1.38 bil...
Innovent Presents Clinical Data of Phase Ia Study for IBI351 (KRAS G12C Inhibitor) as Monotherapy for Solid Tumors at the 2022 Chinese Society of Clinical Oncology (CSCO) Annual Meeting
ROCKVILLE,M.D. and SUZHOU, China, Nov. 14, 2022 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology an...
Telix Acquires Optimal Tracers
MELBOURNE, Australia and INDIANAPOLIS, Ind., Nov. 14, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has entered into an agreement withSacramento-based Northern California PET Imaging Center (NCPIC) to acquire Optimal Tracers, a radiochem...
Telix to Present at Jefferies London Healthcare Conference 2022
MELBOURNE, Australia, Nov. 11, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company), a commercial-stage biopharmaceutical company focused on the development and commercialisation of diagnostic and therapeutic radiopharmaceuticals, advises that DrChristian Behrenbruch,...
Winning the Fight Against Neuropathy in Diabetic Patients
P&G Health and medical experts share clinical guidance in the diagnosis and treatment of nerve damage among diabetic patients MANILA, Philippines, Nov. 11, 2022 /PRNewswire/ -- Ahead of World Diabetes Day 2022, P&G Health, brought together globally renowned multidisciplinary medical experts with...
LOTUS REPORTS ITS BEST QUARTER EVER WITH THE BIGGEST LAUNCH IN ITS HISTORY
TAIPEI, Taiwan, Nov. 11, 2022 /PRNewswire/ -- Lotus Pharmaceutical (1795: TT),
a multinational pharmaceutical company, today reported its financial results
for the third quarter ended30 September 2022.
Mindray Ultrasound Launches Multicenter Research for SEA Regions
BALI, Indonesia, Nov. 11, 2022 /PRNewswire/ -- Themed "Building Bridges, Connecting Visions", Mindray successfully held the 2022 SEA & SA Mindray Ultrasound Forum inBali, Indonesia. More than 150 participants from Indonesia, the Philippines, and Thailand joined the academic forum where experts ex...
Week's Top Stories
Most Reposted
SMU School of Accountancy launches Applied AI Track for next generation of accounting and finance professionals
[Picked up by 282 media titles]
2026-10-07 11:50DayOne Files Registration Statement for Proposed Initial Public Offering
[Picked up by 279 media titles]
2026-10-06 05:28Agoda Partners with Marina Bay Sands on Bespoke Flagship Store for Experience-Led Travel
[Picked up by 277 media titles]
2026-10-08 09:50New Asia Forum Targets US$30 Billion in Investment into the New Asia at Its Inaugural Edition in Bali
[Picked up by 273 media titles]
2026-10-09 13:21The Coffee Bean & Tea Leaf® Turns 63 and Sets a New Direction for Its Next Chapter of Growth
[Picked up by 263 media titles]
2026-10-05 13:24